Utama › Kanser Ovari › California › Baldwin Park
Kajian klinikal Kanser Ovari di Baldwin Park, CA
25 kajian untuk Kanser Ovari sedang mencari peserta di lokasi dalam dan sekitar Baldwin Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site, Duarte · 4 mi jauh
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- City of Hope National Medical Center, Duarte · 4 mi jauh
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi jauh
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- City of Hope, Duarte · 4 mi jauh
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Mengambil pesertaFasa 1
- City of Hope National Medical Center /ID# 281381, Duarte · 4 mi jauh
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Mengambil pesertaFasa 1
- Research Site, Duarte · 4 mi jauh
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Mengambil pesertaFasa 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Mengambil pesertaFasa 3
- City of Hope, Duarte, Duarte · 4 mi jauh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
- City of Hope Cancer Center, Duarte · 4 mi jauh
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Mengambil pesertaFasa 1/2
- City of Hope National Medical Center, Duarte · 4 mi jauh
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Mengambil pesertaFasa 1/2
- City of Hope, Duarte · 4 mi jauh
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Mengambil pesertaFasa 3
- City of Hope Medical Center, Duarte · 4 mi jauh
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Mengambil pesertaFasa 3
- City of Hope, Duarte · 4 mi jauh
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Mengambil peserta
- City of Hope Medical Center, Duarte · 4 mi jauh
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Mengambil peserta
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
AOH1996 for the Treatment of Refractory Solid Tumors
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Mengambil peserta
- Beckman Research Institute of City of Hope, Duarte · 4 mi jauh
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Mengambil pesertaFasa 3
- City of Hope, Duarte · 4 mi jauh
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- City of Hope, Duarte · 4 mi jauh
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Mengambil pesertaFasa 2
- City of Hope National Medical Center, Duarte · 4 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Duarte · 4 mi jauh
Kajian Kanser Ovari di bandar lain
- Houston, TX89 kajian
- New York City, NY69 kajian
- Boston, MA61 kajian
- Los Angeles, CA50 kajian
- Nashville, TN49 kajian
- Arlington, VA46 kajian
- Philadelphia, PA44 kajian
- Columbus, OH39 kajian
- St. Louis, MO38 kajian
- Chicago, IL36 kajian
- San Antonio, TX31 kajian
- Cleveland, OH30 kajian
Kajian lain di Baldwin Park
- Kanser Payudara44 kajian
- Leukemia Mieloid Akut40 kajian
- Kanser Kolorektal37 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)34 kajian
- Kanser Prostat30 kajian
- Kanser Metastatik30 kajian
- Sindrom Mielodisplastik26 kajian
- Kanser Paru-paru24 kajian
- Mieloma Pelbagai23 kajian
- Kanser Perut22 kajian
- Leukemia Limfoblastik Akut21 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.